1. Baum RP, Schmuecking M, Plichta K, Presselt N, Bonnet R, Lopatta E, Niesen A, Przetak C, Leonhardi J (2000) Staging of non small cell lung cancer (NSCLC) — is PET really clinically important or just a research tool? J Nucl Med 41:293P
2. Baum RP, Bonnet RB, Presselt N, Leonhardi J (2001) Positronenemissionstomographie (PET) mit F-18-FDG in der Diagnostik des Bronchialkarzinoms und zur Dignitätsabklärung von pulmonalen Raumforderungen. Nuklearmediziner 24:9–23
3. Baum RP, Rust M, Adams S, Strassmann G, Berekfeld J, Wagner R, Hertel A, Hör G (1996) Influence on patients’ management by whole-body F-18 FDG PET for preoperative staging of non small cell lung cancer. J Nucl Med 37:121P
4. Byhardt RW, Martin L, Pajak TF, Shin KH, Emami B, Cox JD (1993) The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small lung cancer (NSCLC) — analysis of a Radiation Therapy Oncology Group (RTOG) protocol. Int J Radiat Oncol Biol Phys 27:537–544
5. Cai J, Chu JC, Recine D, Sharma M, Nguyen C, Rodebaugh R, Saxena VA, Ali A (1999) CT and PET lung imaging registration and fusion in radiotherapy treatment planning using the chamfer-matching method. Int J Radiat Oncol Biol Phys 43:883–891